Cite
MLA Citation
Joshua A. Tobin et al.. “Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN).” Journal of medical economics, vol. 25, 2022, pp. 1030–1038. http://access.bl.uk/ark:/81055/vdc_100167017300.0x000028